Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Gadicke Ansbert
Relationship:   10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   30,197    

Indirect Shares

   56,162,356      
Direct Value   $24,351    

Indirect Value

   $178,703,966      
Total Shares   56,192,553      
Total Value   $178,728,317      


Allovir Inc $24,351 Allovir Inc $24,351
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -18.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Rigel Pharmaceuticals Inc RIGL Former 10% Owner 2004-07-02 0 2004-09-13 475,026    Premium*  
            Idenix Pharmaceuticals Inc IDIX Director, 10% Owner 2004-07-27 0 2004-07-27 4,797,991    Premium*  
            Radius Health Inc. RDUS Director 0 2016-09-27 3,887,502    Premium*  
            Pacira Pharmaceuticals, Inc. PCRX Former 10% Owner 0 2013-03-11 2,790,479    Premium*  
            Verastem, Inc. VSTM Director 2012-02-01 0 2012-02-01 3,740    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 2012-06-05 0 2012-07-09 1,275,886    Premium*  
            Epizyme, Inc. EPZM 10% Owner 0 2014-02-10 2,413,819    Premium*  
            Aratana Therapeutics, Inc. PETX 10% Owner 2014-03-07 0 2014-03-07 3,388,165    Premium*  
            Chiasma, Inc CHMA Director, 10% Owner 2015-07-21 0 2015-07-21 5,681,544    Premium*  
            Harpoon Therapeutics, Inc. HARP 10% Owner 2019-02-12 0 2019-02-12 8,422,847    Premium*  
            Tcr2 Therapeutics Inc. TCRR Director, 10% Owner 2019-02-19 0 2023-06-01 0    Premium*  
            Repare Therapeutics Inc. RPTX 10% Owner 2020-06-23 0 2021-07-12 3,882,485    Premium*  
            Allovir Inc ALVR Director, 10% Owner 2022-07-28 30,197 2022-07-28 16,674,766    Premium*  
            Dyne Therapeutics, Inc. DYN 10% Owner 2020-09-21 0 2020-09-21 91,081    Premium*  
            Oncorus, Inc. ONCR 10% Owner 0 2020-10-06 2,377,025    Premium*  
* Premium Members only  

Records found :    108         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-07-02 4 D $0.00 $0 D/D (1,447) 0 -
RIGL Rigel Pharmaceuticals Inc Former 10% Owner   –       –      –    2004-09-13 4 D $0.00 $0 I/I (1,687,072) 0 -
RDUS Radius Health Inc. Director   –       •       •   2011-05-17 4 D $0.01 $50,000 I/I (5,000,000) 0 0 -
PETX Aratana Therapeutics, Inc... 10% Owner   –       –       •   2014-03-07 4 S $20.16 $538,534 D/D (26,713) 0 0 -
TCRR Tcr2 Therapeutics Inc. Director   –       •       •   2023-06-01 4 D $0.00 $0 I/I (7,529,946) 0 0 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-07-02 4 S $14.59 $35,930 D/D (2,463) 1,447 -
VSTM Verastem, Inc. Director   –       •      –    2012-02-01 4 B $10.00 $1,000,000 I/I 100,000 3,740 2.1 -
ALVR Allovir Inc Director   –       •       •   2020-07-29 3 IO $0.00 $0 D/D 0 30,197 -
DYN Dyne Therapeutics, Inc. 10% Owner   –       –       •   2020-09-21 4 A $0.00 $0 I/I 4,951,303 91,081 0 -
PCRX Pacira Pharmaceuticals, I... 10% Owner   –       –       •   2011-02-02 3 IO $0.00 $0 I/I 0 92,980 -
ONCR Oncorus, Inc. 10% Owner   –       –       •   2020-10-01 3 IO $0.00 $0 I/I 0 115,823 -
EPZM Epizyme, Inc. 10% Owner   –       –       •   2013-05-30 3 IO $0.00 $0 I/I 0 178,331 -
TCRR Tcr2 Therapeutics Inc. Director   –       •       •   2023-05-22 4 S $1.88 $131,920 I/I (70,170) 304,001 0 %
TCRR Tcr2 Therapeutics Inc. Director   –       •       •   2023-05-22 4 OE $0.74 $131,919 I/I 178,269 374,171 0 -
RIGL Rigel Pharmaceuticals Inc Former 10% Owner   –       –      –    2004-09-13 4 A $0.00 $0 I/I 475,026 475,026 -
SOMX Somaxon Pharmaceuticals, ... 10% Owner   –       –       •   2012-07-09 4 S $0.31 $498,744 I/I (1,624,574) 1,275,886 0 -
TCRR Tcr2 Therapeutics Inc. Director   –       •       •   2019-02-19 4 B $15.00 $20,599,995 I/I 1,373,333 1,569,235 2.25 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-09-01 4 S $21.13 $517,719 I/I (24,500) 1,687,072 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-31 4 S $20.60 $1,246,626 I/I (60,527) 1,711,572 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-25 4 S $19.77 $16,330 I/I (826) 1,772,099 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-20 4 S $21.84 $600,619 I/I (27,499) 1,772,925 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-19 4 S $21.77 $108,847 I/I (5,000) 1,800,424 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-18 4 S $21.80 $117,720 I/I (5,400) 1,805,424 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-17 4 S $22.44 $305,216 I/I (13,599) 1,810,824 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-13 4 S $22.30 $223,000 I/I (10,000) 1,824,423 -
  108  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us